🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alexey V. Sorokin

The University of Texas MD Anderson Cancer Center

ORCID: 0009-0000-7195-6868
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
3.4Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3
Top 8%
2.7DataRank
Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

Papers

Driven by 16 papers — median percentile 81. Top paper: “Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment”.

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Nature Communications(2021)10.1038/s41467-021-25177-3
Top 8%
2.7DataRank
Top 8%109 citations

Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl +94 more

KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

Cell Reports(2022)10.1016/j.celrep.2022.110993
N/A
0.769DataRank · unranked
168 citations

Oluwadara Coker, Alexey V. Sorokin, Katerina A. Fella, Haley Barnes, Edmond Wong +7 more

PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

NAR Cancer(2022)10.1093/narcan/zcac014
Top 31%
0.652DataRank
Top 31%22 citations

Michael W. Lloyd, Jeffrey W. Grover, Nan Xiao, Sara Seepo, Sai Lakshmi Subramanian +95 more

Clinical and Functional Characterization of Atypical KRAS / NRAS Mutations in Metastatic Colorectal Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0180
N/A
0.553DataRank · unranked
39 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1166
N/A
0.449DataRank · unranked
19 citations

Ajay Kumar Saw, Van K. Morris, Stefania Napolitano, Christopher A. Bristow, Sanjana Srinivasan +11 more

Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0110
N/A
0.330DataRank · unranked
8 citations

Fan Fan, Reid T. Powell, Jason Roszik, Yong Sung Park, Clifford Stephan +8 more

Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo

PLoS ONE(2023)10.1371/journal.pone.0281063
N/A
0.330DataRank · unranked
8 citations

Susmita Ghosh, Reid T. Powell, Jason Roszik, Yongsun Park, Mary Sobieski +6 more

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102253
N/A
0.269DataRank · unranked
5 citations

Mitsunobu Takeda, Alexey V. Sorokin, Shuaitong Chen, Zecheng Yang, Xiaofei Wang +25 more

Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts

Frontiers in Oncology(2022)10.3389/fonc.2022.994333
N/A
0DataRank · unranked
20 citations

Alexey V. Sorokin, Lea Bitner, Rebecca Aden, Michael Lam, Ganiraju C. Manyam +8 more

Data from Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

(2023)10.1158/0008-5472.c.6513959.v1
N/A
0DataRank · unranked
0 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

Supplementary Figure from Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

(2023)10.1158/0008-5472.22431731
N/A
0DataRank · unranked
0 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6530433
N/A
0DataRank · unranked
0 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Data from Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer

(2023)10.1158/1078-0432.c.6530433.v1
N/A
0DataRank · unranked
0 citations

Yucai Wang, Muddassir Syed, Alexey V. Sorokin, Oluwadara Coker, Joanne Xiu +17 more

Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6

Cancer Research(2022)10.1158/0008-5472.can-22-0198
N/A
0DataRank · unranked
81 citations

Preeti Kanikarla Marie, Lea Bitner, Muddassir Syed, Melanie Woods, Ganiraju C. Manyam +8 more

Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3133
N/A
0DataRank · unranked
16 citations

Seong-Woo Bae, Jennifer G. Whisenant, Gregory D. Ayers, Quanhu Sheng, Todd E. Peterson +15 more

Encorafenib, cetuximab, and cytotoxic chemotherapy combinations in BRAFV600E CRC murine models.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.145
N/A
0DataRank · unranked
0 citations

Vincenzo De Falco, Claudia Prisco, Giulia Martini, Luigi Pio Guerrera, Valentina Belli +11 more